Guide for Primary Health Care Providers: Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection 2005

Return to Table of Contents

Appendix C

Administration and Measurement of the TST*

Administration
The Mantoux test is the recommended TST. It is administered by injecting 0.1 ml of 5 TU of purified protein derivative (PPD) solution intradermally into the volar surface of the forearm using a 27-gauge needle with a tuberculin syringe.

• Obtain results of all previous TST. Ask patient to describe what the test area looked like 2–3 days after administration; obtain documentation
• Avoid areas of skin with veins, rashes, or excess hair
• Cleanse the area with alcohol swab, allow area to dry, and inject all antigen just below the surface of the skin on the volar surface of the forearm, forming a 6–10 mm wheal (a pale, raised area with distinct edges; has orange-peel appearance and does not disappear immediately)
• If no wheal forms, or if a wheal forms that is less than 6 mm, the test should be repeated immediately, approximately 2 inches from original site or on the other arm
• If minor bleeding occurs, dab the injection site with a cotton swab
• Avoid covering the area with a bandage or applying pressure to the injection site
• Record the date, time, and location of the TST
• Instruct patient not to scratch the site, but to use cool compress to relieve any itching or swelling
• Inform patient of the importance of returning for a reading of the TST within 48–72 hours (2–3 days)
• Give written appointment card for TST reading
• Provide written information about TST (pamphlet or brochure)

Measurement

• Measure the induration (hard bump) rather than erythema
• Palpate area with fingertips, measuring the diameter of induration perpendicular to the long axis of the arm
• Use ballpoint pen to mark edges of induration
• Use a tuberculin skin testing ruler or ruler with millimeters to measure the distance between the two points

Recording and documentation

• Record date TST was administered
• Record the brand name of the PPD solution, lot number, manufacturer, and expiration date on the patient record
• Record results in millimeters of induration (0 mm if there is no induration) rather than as positive or negative
• Record date and time of reading and name of person reading TST
• Provide patient and ordering physician with written documentation

Storage and Handling

• PPD solution must be kept refrigerated at 36°– 46° F
• Avoid fluctuations in temperature; do not store on the refrigerator door
• Syringes must be filled immediately prior to administration
• Store and transport the tuberculin in the dark as much as possible and avoid exposure to light.

*Contact the local health department TB program for training on the Mantoux tuberculin skin test.

Last Reviewed: 05/18/2008
Content Source: Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

 
Back to Top of Page

If you would like to order any of the DTBE publications please visit the online order form.

You will need Adobe Acrobat™ Reader v5.0 or higher to read pages that are in PDF format.  Download the Adobe Acrobat™ Reader.

If you have difficulty accessing any material on the DTBE Web site because of a disability, please contact us in writing or via telephone and we will work with you to make the information available.

Division of Tuberculosis Elimination
Attn: Content Manager, DTBE Web site
Centers for Disease Control and Prevention
1600 Clifton Rd., NE Mailstop E-10
Atlanta, GA 30333
CDC-INFO at (1-800) 232-4636
TTY: 1 (888) 232-6348
E-mail: cdcinfo@cdc.gov

Home | Site Map | Contact Us
Accessibility | Privacy Policy Notice | FOIA | USA.gov
CDC Home | Search | Health Topics A-Z

Centers for Disease Control & Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Please send comments/suggestions/requests to: CDCINFO@cdc.gov